Skip to Content

HAW/240 (Xpect-AT 60 mg-600 mg)

Generic Name: carbetapentane/guaifenesin

Pill imprint HAW/240 has been identified as Xpect-AT 60 mg-600 mg.

Xpect-AT is used in the treatment of cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Xpect-AT 60 mg-600 mg is not a controlled substance under the Controlled Substance Act (CSA).

Xpect-AT
Generic Name:
carbetapentane/guaifenesin
Imprint:
HAW/240
Strength:
60 mg-600 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Hawthorn Pharmaceuticals

More info Print Imprint Search

More about Xpect-AT (carbetapentane / guaifenesin)

Consumer resources

Other formulations

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide